Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U... Show more
HROW is expected to report earnings to rise 40.15% to 46 cents per share on March 25
Q4'25
Est.
$0.46
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.23
Q1'25
Missed
by $0.56
Q4'24
Beat
by $0.11
The last earnings report on November 10 showed earnings per share of 33 cents, beating the estimate of 23 cents. With 414.50K shares outstanding, the current market capitalization sits at 1.42B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HROW showed earnings on November 10, 2025. You can read more about the earnings report here.